Location: In-person at Stanford and virtual
Please check back for updates on speakers, agenda, and registration information.
Welcome to the 2025 Stanford Drug Discovery Symposium. This event has become a cornerstone in the drug discovery community for networking and collaboration. It offers a unique opportunity for all members of the drug discovery community – including researchers, pharmaceutical companies, investment groups, academia, and the broader biomedical community – to share ideas and innovations. We anticipate two days of exciting talks and discussions, including the return of our poster session. We look forward to welcoming you to Stanford for SDDS 2025.
— Joseph C. Wu, MD, PhD | Director, Cardiovascular Institute
Participants
Carolyn Bertozzi, PhD
Nobel Laureate 2022
Baker Family Director of Stanford ChEM-H
Patrizia Cavazzoni, MD
Director, Center for Drug Evaluation and Resarch Food and Drug Administration
Karen Knudsen, MBA, PhD
CEO, American Cancer Society & American Cancer Society Cancer Action Network
Stephen Quake, D.Phil
Head of Science, Chan Zuckerberg Initiative
Robert Blum, MBA
President and CEO, Cytokinetics
Aida Habtezion, MD
Chief Medical Officer and Head of Worldwide Medical and Security, Pfizer
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research, Food and Drug Administration
John Reed, MD, PhD
Executive Vice President, Innovation Medicine, R&D, Johnson & Johnson
Rob Califf, MD
Commissioner, U.S. Food and Drug Administration
Stephen Hoge, MD
President, Moderna
Andrew Plump, MD, PhD
President of Research and Development, Takeda
Lifetime Achievement Awardees
TBD
Event Program & Poster
TBD
FAQs
Foundation Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Media Partners
Organizers
Amanda Chase, PhD
Associate Director of Strategic Research Development
Stanford Cardiovascular Institute
Kuldev Singh, MD
Professor of Ophthalmology
Stanford University School of Medicine
Sanjay Malhotra, PhD
Professor, Cell, Developmental & Cancer Biology; Director, Center for Experimental Therapeutics
OHSU
Joseph Wu, MD, PhD
Director, Stanford CVI
Simon H. Stertzer, MD, Professor, Department of Medicine and Radiology
Stanford University School of Medicine
Mark Mercola, PhD
Professor of Medicine
Stanford University School of Medicine
Francesca Mae G. Tongco, MS-HCA
Project Coordinator
Stanford Cardiovascular Institute
For additional information, please contact Joseph C. Wu, MD, PhD, or Francesca Tongco.